Nanotechnology

Original Editor -User:Maria Elia

Top Contributors - Maria Elia  

Introduction

Nanotechnology is a relatively new cross-disciplinary field in modern science that deals with materials and interactions at the molecular or even atomic level, with sizes ranging from 0.1 to 100 nm (1 nm = 10Ϗρ9 m). It lies at the intersection of physics, chemistry, biology, and engineering sciences.These materials are known to have different physical and chemical properties (such as optical qualities, chemical interactions, conductance, magnetism, and so on) than larger-scale materials because of their tiny size . At these minuscule scales, the material's surface undergoes substantial changes, as do its optical, chemical, and magnetic properties; molecular recognition diverges greatly from macroscale processes; quantum effects may predominate over classical physics; and novel and unpredictable effects may manifest. Cell cultures, biosensors, diagnostic tests, tissue regeneration, nano-robots for repairing and/or replacing cell structures, genetic engineering, anti-infectious agents, cancer and diabetes treatment, vaccine delivery, and other fields have all benefited greatly from their applications in medicine (for diagnostic, therapeutic, and prophylactic purposes) .

DNA and RNA Differences https://www.thoughtco.com/dna-versus-rna-608191

Interaction of nanoparticles with biological molecules

Nanoparticles' Interaction with Biological Molecules Nanoparticles can actively interact with biological systems because they match and correspond with natural molecules and functional systems found in living things . Nanoparticles and nanosized devices can enter living cells and subcellular structures (organelles) and interact with intracellular molecules like proteins and ribonucleic acids (DNA and RNA) because most animal cells are between 10 and 20,000 nm in size.

Various kinds of nanoparticles are employed in the medical domain.

Because of their nanoscale size, nanoparticles have a large surface-area-to-volume ratio that enables them to swiftly circulate throughout the bloodstream and absorb large amounts of medication. They have unique properties due to their larger surface area, which also improves their mechanical, magnetic, optical, and catalytic properties, making them more useful in pharmaceutical applications. Based on their chemical makeup, nanoparticles are divided into three categories: carbon-based, inorganic, and organic.

Areas of application in medicine

1. identification of protein biomarkers and/or alterations in DNA
2. controlled release of drugs visualization boost the solubility of drugs
3. find mutated DNA fragments
4. visualization of lymph nodes and tumors
5. imaging of tumors
6. ablation of tumors protein and chemical sensing
7. personalized medication administration

Nanotechnology and rehabilitation

Cancer treatment video link that explains the process

Diagnosis and nanotechnology

In vitro and in vivo diagnostics using nanomaterials present a unique opportunity for noninvasive, quick, and affordable methods—even in real time—for nontoxic imaging studies and simultaneous diagnostic and therapeutic approaches, or “theranostics,” which refers to targeted diagnostic methods combined with prompt therapeutic intervention. Examples of this include the visualization of tumor cells using magnetic nanoparticles followed by magnetism-induced thermal ablation or the visualization of the tumor using antibody-bound gold nanoshells followed by infrared light and thermal ablation. For accurate and noninvasive in vivo sensing, NEMS can be employed. Additionally, the small size of the nanoparticles reduces the need for biopsy by enabling accurate and quick DNA sequencing, in vivo staining and visualization, and targeted imaging of damaged cells and tissues.

Conclusion

As with most high-tech products, it takes ten to fifteen years for an advanced medical technology to hit the market, given the strict regulations that surround the medical industry. It is anticipated that a sizable number of approved nanodrugs or nanodevices will be approved in the early 2010s, given the substantial efforts made in basic research related to nanomedicine in the early 2000s. The FDA has approved 22 nanodrugs thus far, and many more are undergoing phase II or even III clinical trials. Approximately twenty-five clinical trials were ongoing in Europe in 2010. Simultaneously, an increasing number of SMEs and spin-off businesses use nanotechnologies to target medical applications, sometimes in niche markets, helping to validate novel concepts. Large-scale forecasting is simple.